-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $130

Benzinga·12/17/2025 13:04:35
語音播報
Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $110 to $130.